Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma

Mayumi Egawa, Yuichi Yoshida, Satoshi Ogura, Tomohide Kurahashi, Takashi Kizu, Kunimaro Furuta, Yoshihiro Kamada, Norihiro Chatani, Mina Hamano, Shinichi Kiso, Hayato Hikita, Tomohide Tatsumi, Hidetoshi Eguchi, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Tetsuo Takehara

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Aim: Forkhead Box M1 (FoxM1) is a proliferation-specific transcription factor. In this study, we aimed to elucidate the clinicopathological and prognostic values of FoxM1 expression in human hepatocellular carcinoma (HCC) and correlate FoxM1 expression with various etiologies of liver diseases. We also investigated its therapeutic value in HCC. Methods: We investigated the expression of FoxM1 in tumor tissues and adjacent non-tumor tissues of 79 Japanese HCC patients by quantitative real-time reverse transcription–polymerase chain reaction analysis. Depletion by siRNA or specific inhibition by siomycin A were also used to investigate the effect of FoxM1 inhibition on stem-like features of human HCC cells. Results: Quantitative real-time reverse transcription–polymerase chain reaction analysis showed that tumor tissues displayed an approximately 14-fold increase in FoxM1 expression compared with adjacent non-tumor tissues. Interestingly, the expression levels of FoxM1in tumor tissues did not depend on the etiology of liver disease. The expression of FoxM1 in tumor tissues was associated with serum α-fetoprotein level, maximum tumor size, histological grade, TNM staging, and portal involvement. Kaplan–Meier analysis indicated that the high FoxM1 expression (≥median) group had a poor prognosis compared with the low FoxM1 expression (<median) group. Using multivariate analysis, the expression of FoxM1 in tumor tissues was shown to be an independent prognostic factor that affected overall survival and disease-free survival. Furthermore, FoxM1 inhibition by siRNA or siomycin A reduced spheroid colony formation of HCC cells in vitro. Conclusion: Our data suggest that FoxM1 might be a prognostic biomarker and a promising therapeutic target for HCC.

Original languageEnglish
Pages (from-to)1196-1205
Number of pages10
JournalHepatology Research
Volume47
Issue number11
DOIs
Publication statusPublished - Oct 1 2017
Externally publishedYes

Fingerprint

Forkhead Transcription Factors
Hepatocellular Carcinoma
Neoplasms
Small Interfering RNA
Liver Diseases
Fetal Proteins
Neoplasm Staging
Disease-Free Survival
Transcription Factors
Multivariate Analysis
Biomarkers
Survival
Therapeutics
Serum

All Science Journal Classification (ASJC) codes

  • Hepatology
  • Infectious Diseases

Cite this

Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma. / Egawa, Mayumi; Yoshida, Yuichi; Ogura, Satoshi; Kurahashi, Tomohide; Kizu, Takashi; Furuta, Kunimaro; Kamada, Yoshihiro; Chatani, Norihiro; Hamano, Mina; Kiso, Shinichi; Hikita, Hayato; Tatsumi, Tomohide; Eguchi, Hidetoshi; Nagano, Hiroaki; Doki, Yuichiro; Mori, Masaki; Takehara, Tetsuo.

In: Hepatology Research, Vol. 47, No. 11, 01.10.2017, p. 1196-1205.

Research output: Contribution to journalArticle

Egawa, M, Yoshida, Y, Ogura, S, Kurahashi, T, Kizu, T, Furuta, K, Kamada, Y, Chatani, N, Hamano, M, Kiso, S, Hikita, H, Tatsumi, T, Eguchi, H, Nagano, H, Doki, Y, Mori, M & Takehara, T 2017, 'Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma', Hepatology Research, vol. 47, no. 11, pp. 1196-1205. https://doi.org/10.1111/hepr.12854
Egawa, Mayumi ; Yoshida, Yuichi ; Ogura, Satoshi ; Kurahashi, Tomohide ; Kizu, Takashi ; Furuta, Kunimaro ; Kamada, Yoshihiro ; Chatani, Norihiro ; Hamano, Mina ; Kiso, Shinichi ; Hikita, Hayato ; Tatsumi, Tomohide ; Eguchi, Hidetoshi ; Nagano, Hiroaki ; Doki, Yuichiro ; Mori, Masaki ; Takehara, Tetsuo. / Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma. In: Hepatology Research. 2017 ; Vol. 47, No. 11. pp. 1196-1205.
@article{9c372d07e5bf4fffb5ed5ff169857593,
title = "Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma",
abstract = "Aim: Forkhead Box M1 (FoxM1) is a proliferation-specific transcription factor. In this study, we aimed to elucidate the clinicopathological and prognostic values of FoxM1 expression in human hepatocellular carcinoma (HCC) and correlate FoxM1 expression with various etiologies of liver diseases. We also investigated its therapeutic value in HCC. Methods: We investigated the expression of FoxM1 in tumor tissues and adjacent non-tumor tissues of 79 Japanese HCC patients by quantitative real-time reverse transcription–polymerase chain reaction analysis. Depletion by siRNA or specific inhibition by siomycin A were also used to investigate the effect of FoxM1 inhibition on stem-like features of human HCC cells. Results: Quantitative real-time reverse transcription–polymerase chain reaction analysis showed that tumor tissues displayed an approximately 14-fold increase in FoxM1 expression compared with adjacent non-tumor tissues. Interestingly, the expression levels of FoxM1in tumor tissues did not depend on the etiology of liver disease. The expression of FoxM1 in tumor tissues was associated with serum α-fetoprotein level, maximum tumor size, histological grade, TNM staging, and portal involvement. Kaplan–Meier analysis indicated that the high FoxM1 expression (≥median) group had a poor prognosis compared with the low FoxM1 expression (",
author = "Mayumi Egawa and Yuichi Yoshida and Satoshi Ogura and Tomohide Kurahashi and Takashi Kizu and Kunimaro Furuta and Yoshihiro Kamada and Norihiro Chatani and Mina Hamano and Shinichi Kiso and Hayato Hikita and Tomohide Tatsumi and Hidetoshi Eguchi and Hiroaki Nagano and Yuichiro Doki and Masaki Mori and Tetsuo Takehara",
year = "2017",
month = "10",
day = "1",
doi = "10.1111/hepr.12854",
language = "English",
volume = "47",
pages = "1196--1205",
journal = "Hepatology Research",
issn = "1386-6346",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma

AU - Egawa, Mayumi

AU - Yoshida, Yuichi

AU - Ogura, Satoshi

AU - Kurahashi, Tomohide

AU - Kizu, Takashi

AU - Furuta, Kunimaro

AU - Kamada, Yoshihiro

AU - Chatani, Norihiro

AU - Hamano, Mina

AU - Kiso, Shinichi

AU - Hikita, Hayato

AU - Tatsumi, Tomohide

AU - Eguchi, Hidetoshi

AU - Nagano, Hiroaki

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Takehara, Tetsuo

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Aim: Forkhead Box M1 (FoxM1) is a proliferation-specific transcription factor. In this study, we aimed to elucidate the clinicopathological and prognostic values of FoxM1 expression in human hepatocellular carcinoma (HCC) and correlate FoxM1 expression with various etiologies of liver diseases. We also investigated its therapeutic value in HCC. Methods: We investigated the expression of FoxM1 in tumor tissues and adjacent non-tumor tissues of 79 Japanese HCC patients by quantitative real-time reverse transcription–polymerase chain reaction analysis. Depletion by siRNA or specific inhibition by siomycin A were also used to investigate the effect of FoxM1 inhibition on stem-like features of human HCC cells. Results: Quantitative real-time reverse transcription–polymerase chain reaction analysis showed that tumor tissues displayed an approximately 14-fold increase in FoxM1 expression compared with adjacent non-tumor tissues. Interestingly, the expression levels of FoxM1in tumor tissues did not depend on the etiology of liver disease. The expression of FoxM1 in tumor tissues was associated with serum α-fetoprotein level, maximum tumor size, histological grade, TNM staging, and portal involvement. Kaplan–Meier analysis indicated that the high FoxM1 expression (≥median) group had a poor prognosis compared with the low FoxM1 expression (

AB - Aim: Forkhead Box M1 (FoxM1) is a proliferation-specific transcription factor. In this study, we aimed to elucidate the clinicopathological and prognostic values of FoxM1 expression in human hepatocellular carcinoma (HCC) and correlate FoxM1 expression with various etiologies of liver diseases. We also investigated its therapeutic value in HCC. Methods: We investigated the expression of FoxM1 in tumor tissues and adjacent non-tumor tissues of 79 Japanese HCC patients by quantitative real-time reverse transcription–polymerase chain reaction analysis. Depletion by siRNA or specific inhibition by siomycin A were also used to investigate the effect of FoxM1 inhibition on stem-like features of human HCC cells. Results: Quantitative real-time reverse transcription–polymerase chain reaction analysis showed that tumor tissues displayed an approximately 14-fold increase in FoxM1 expression compared with adjacent non-tumor tissues. Interestingly, the expression levels of FoxM1in tumor tissues did not depend on the etiology of liver disease. The expression of FoxM1 in tumor tissues was associated with serum α-fetoprotein level, maximum tumor size, histological grade, TNM staging, and portal involvement. Kaplan–Meier analysis indicated that the high FoxM1 expression (≥median) group had a poor prognosis compared with the low FoxM1 expression (

UR - http://www.scopus.com/inward/record.url?scp=85011675564&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85011675564&partnerID=8YFLogxK

U2 - 10.1111/hepr.12854

DO - 10.1111/hepr.12854

M3 - Article

VL - 47

SP - 1196

EP - 1205

JO - Hepatology Research

JF - Hepatology Research

SN - 1386-6346

IS - 11

ER -